The Impact of Patient Motivational Dialogue (PMD) on Patient Self-advocacy for Hand Hygiene

Sponsor
The University of Texas Health Science Center at San Antonio (Other)
Overall Status
Completed
CT.gov ID
NCT04360057
Collaborator
(none)
63
1
1
17.3
3.6

Study Details

Study Description

Brief Summary

This exploratory cross sectional cohort study will evaluate the feasibility and fidelity of using an innovative strategy, the Patient Motivational Dialogue (PMD)/PMDPlus that will intentionally motivate and encourage the patient toward self-advocacy for their Health Care Professional's (HCP's) hand hygeine (HH) adherence.

Condition or Disease Intervention/Treatment Phase
  • Other: PMD
  • Other: PMDPlus
N/A

Detailed Description

This study will be implemented with two volunteer innovation champion physicians, one in radiation oncology and one in the chemotherapy oncology clinic. If other physicians begin to use the PMD/ PMDPlus in their clinics, the initiation will be considered a positive indication of feasibility and fidelity.

New patients will be enrolled in the study starting September 2016 until the sample size reaches 30 patients per clinic (n=60). Each patient will be followed in each clinic visit longitudinal through March 2017 or until discharged from the clinic treatment depending on which comes first. PMD will be administered in the first clinic visit followed by the PMDPlus each visit thereafter to ensure an adequate treatment dose. The PMD is estimated to take about two minutes of the initial clinic visit and the PMDPlus is estimated to take about one minute of the follow-up clinic visit.

The following steps will be taken based on the innovation decision model:
  1. The PI will instruct the physicians, or designee in the use of the PMD/PMDPlus. Script cards with the PMD/PMDPlus will be provided to each physician. The physician will be instructed in use of PMD at the initial visit and the PMDPlus every follow-up clinic visit thereafter until discharge from the clinic.

  2. A HCP survey will be conducted pre-intervention asking the HCP: "Has a patient or family ever ask you to clean your hands? If yes, the HCP will be asked to describe the situation.

Study Design

Study Type:
Interventional
Actual Enrollment :
63 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Subjects will be included from two oncology clinics, one in radiation oncology and one in chemotherapy oncologySubjects will be included from two oncology clinics, one in radiation oncology and one in chemotherapy oncology
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
The Impact of Patient Motivational Dialogue (PMD) on Patient Self-advocacy for Hand Hygiene: A Feasibility Study
Actual Study Start Date :
Oct 1, 2016
Actual Primary Completion Date :
May 30, 2017
Actual Study Completion Date :
Mar 13, 2018

Arms and Interventions

Arm Intervention/Treatment
Other: Hand Hygiene education

Other: PMD
A script used to train the physician to engage with the patient in the topic of hand hygiene compliance used on the initial visit.
Other Names:
  • Patient Motivational Dialogue
  • Other: PMDPlus
    A script used to train the physician to engage with the patient in the topic of hand hygiene compliance on follow up visits
    Other Names:
  • Patient Motivational Dialogue Plus
  • Outcome Measures

    Primary Outcome Measures

    1. The Impact of Patient Motivational Dialogue (PMD) on Patient Self-advocacy for Hand Hygiene [At treatment completion, an average of 4-6 months]

      At the last clinic visit, the PI or research assistant will ask the patient this nominal question: "Have you ever ask your physician or your HCP to clean their hands during your visits here?" If yes, describe the circumstances. If no, describe why not. Verbal responses will be recorded.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    3 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • English or Spanish speaking

    • Able to understand instructions given by physician

    • Receiving care in radiation oncology clinic and/or chemotherapy clinic at Cancer Therapy Research Center at University of Texas Health Science Center (UTHSCSA)

    Exclusion Criteria:
    • Unable to understand instructions given by physician

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cancer Therapy & Research Center at UTHSCSA San Antonio Texas United States 78229

    Sponsors and Collaborators

    • The University of Texas Health Science Center at San Antonio

    Investigators

    • Principal Investigator: Patti G Grota, University of Texas Health at San Antonio
    • Principal Investigator: Tony Eng, MD, University of Texas Health at San Antonio

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    The University of Texas Health Science Center at San Antonio
    ClinicalTrials.gov Identifier:
    NCT04360057
    Other Study ID Numbers:
    • HSC20160369H
    First Posted:
    Apr 24, 2020
    Last Update Posted:
    Apr 24, 2020
    Last Verified:
    Apr 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by The University of Texas Health Science Center at San Antonio

    Study Results

    No Results Posted as of Apr 24, 2020